Oncology
1888 — Otto Lubarsch's post-mortem documentation of multiple small intestinal tumors, Germany
Neuroendocrine tumors were poorly understood for much of medical history, often misidentified or overlooked entirely due to their variable and subtle clinical presentations. The formal recognition of these growths as a distinct pathological category emerged gradually through the work of nineteenth and early twentieth century pathologists. Their origins in hormone-producing cells scattered throughout the body made them a subject of fascination once endocrinology began to mature as a discipline.
Historical Narrative
For most of recorded medical history, the growths now recognized as neuroendocrine tumors were invisible to physicians as a unified category. Ancient healers and medieval scholars who encountered abdominal masses or unusual wasting illnesses lacked the conceptual framework to distinguish tumors arising from specialized hormone-secreting cells from other internal growths. Hippocratic writers described mysterious internal swellings and attributed them to imbalances of the four humors, particularly an excess of black bile, which was thought to be the root cause of all tumorous conditions. This humoral explanation persisted through the Galenic tradition and dominated European medicine well into the Renaissance.
The first meaningful steps toward identifying what would later be called neuroendocrine tumors came with the gradual development of pathological anatomy in the seventeenth and eighteenth centuries. Physicians such as Giovanni Battista Morgagni, whose landmark 1761 work 'De Sedibus et Causis Morborum' correlated clinical observations with autopsy findings, helped establish the idea that specific diseases could be traced to lesions in specific organs. This laid groundwork for later investigators to examine unusual intestinal and pancreatic growths with fresh eyes.
In 1867, the German physician Theodor Langhans described small, unusual cell clusters in the intestinal wall that distinguished themselves from ordinary cancerous tissue by their compact, almost benign-appearing architecture. Around the same period, Rudolf Virchow, the towering figure of cellular pathology, provided the intellectual foundation for understanding tumors at the cellular level, which would eventually allow pathologists to begin categorizing these peculiar growths more precisely.
The pivotal moment in the formal history of neuroendocrine tumors came in 1888, when Otto Lubarsch documented multiple small tumors of the small intestine during post-mortem examination. Then in 1907, the German pathologist Siegfried Oberndorfer coined the term 'Karzinoid,' meaning carcinoid or 'cancer-like,' to describe these intestinal tumors that appeared histologically malignant yet behaved in a comparatively indolent fashion. Oberndorfer's terminology, later Anglicized to 'carcinoid,' became the dominant label for decades and represented the first time these tumors were conceptualized as a distinct pathological entity.
The endocrine dimensions of these tumors began to be appreciated in the early twentieth century as the science of hormones expanded rapidly. Researchers began to suspect that some tumors produced biologically active substances that caused systemic effects. In the 1950s, the Norwegian physician Bjørn Thorson and his colleagues, along with independent work by Clarence G. Bywaters and others, described the constellation of flushing, diarrhea, and cardiac changes that became known as carcinoid syndrome, firmly linking certain tumors to excessive hormone secretion.
The discovery that these tumors arose from cells of neural crest origin and shared properties with endocrine glands led Anthony Pearse in the 1960s to propose the APUD cell concept, situating carcinoid and related tumors within a broader family of neuroendocrine neoplasms. This conceptual revolution reframed scattered clinical observations accumulated over a century and established the theoretical basis upon which later classification systems were built. By the latter decades of the twentieth century, pathologists and oncologists had moved toward a comprehensive taxonomy that grouped carcinoids, islet cell tumors, and similar growths under the umbrella term neuroendocrine tumors, acknowledging both their shared cellular heritage and their remarkable biological diversity.
Key Historical Figures
Historical narrative only — this page describes how Neuroendocrine tumor was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.